Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Total 13F shares
-
39,831,678
-
Share change
-
+1,345,133
-
Total reported value
-
$333,392,000
-
Put/Call ratio
-
115%
-
Price per share
-
$8.37
-
Number of holders
-
65
-
Value change
-
+$12,212,303
-
Number of buys
-
38
-
Number of sells
-
24
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q3 2021
As of 30 Sep 2021,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,831,678 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., GOLDMAN SACHS GROUP INC, DRIEHAUS CAPITAL MANAGEMENT LLC, JENNISON ASSOCIATES LLC, Opaleye Management Inc., FIL Ltd, and GILDER GAGNON HOWE & CO LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.